FRANKLIN FTSE EMERGING MARKETS UCITS ETF

Issuer: Franklin Templeton

Asset Class: Equity

TER: 19bps

Trading Currency: USD

Pays Income: False

Listing Date: 24 Oct 2024

Ticker: EMGM

ISIN: IE0004I037N4

This investment vehicle offers exposure to the performance of large and mid-capitalisation stocks from a diverse range of emerging market countries. By aiming to replicate the FTSE Emerging Index, it provides a broad, market-cap-weighted portfolio that captures the economic dynamism of developing nations. The underlying index includes companies from key economies such as China, India, Taiwan, Brazil, and South Africa, offering investors a single-trade solution for diversified access to these high-growth potential regions. The fund is designed for those looking to build a core emerging markets allocation within a global equity portfolio, balancing the opportunity for significant capital appreciation with the inherent diversification of holding hundreds of individual securities across multiple sectors and countries.

Investing in emerging markets can be a strategic component for long-term growth, as these economies often expand at a faster pace than their developed counterparts. Key drivers include favourable demographics, a burgeoning middle class with increasing consumer demand, and ongoing industrialisation and technological adoption. While this growth potential is attractive, it is accompanied by higher levels of risk, including currency volatility, political instability, and less mature regulatory environments. This fund mitigates some of the specific company risks through its broad diversification, but investors should be prepared for greater price fluctuations compared to investments in developed markets. It serves as an efficient tool for capturing the general market trend, or beta, of the emerging market asset class.

The fund employs a physical replication strategy, meaning it purchases and holds the actual constituent stocks of the benchmark index. This approach provides transparency and eliminates the counterparty risk associated with synthetic replication methods that use derivatives. As a UCITS-compliant fund, it adheres to European regulatory standards designed to protect investors. Its competitive expense ratio ensures that costs do not significantly erode returns over the long term, making it a cost-effective vehicle for gaining strategic exposure to the world's most dynamic and evolving economies.